US Capitol Capsule: Stem cell researchers breathe sigh of relief on vacated injunction
This article was originally published in Scrip
Executive Summary
Researchers last week cheered a 29 April ruling by a US appeals court that vacated an injunction imposed last August by a lower court on federal funding for research involving human embryonic stem cells (hESCs) – with the latest decision giving the Obama administration a big win in the case. The ruling also bodes well for companies involved in hESC research, although the 29 April decision has no impact on the clinical trials underway by the two US firms already given the US FDA's blessing to move forward.